FDA NDC Directory · JSON-LD · Markdown

Uceris

NDC 68012-309 · HUMAN PRESCRIPTION DRUG · TABLET, EXTENDED RELEASE

Generic namebudesonide
Labeler / ManufacturerSantarus Inc.
Marketing categoryNew Drug Application (innovator) · App NDA203634
Dosage form / routeTABLET, EXTENDED RELEASE · ORAL
Active ingredientsBUDESONIDE (9 mg/1)
Marketing started20130114
Package count3

External sources

Source: openFDA. Public-domain (CC0).